Synta Pharmaceuticals Corp (NASDAQ:SNTA)

2.27
Delayed Data
As of May 22
 -0.02 / -0.87%
Today’s Change
1.85
Today|||52-Week Range
4.97
-14.34%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Operating ActivitiesNet Income / Starting Line-22.3M-20.0M-20.4M--
 
 
 
 
Depreciation169.0K167.0K169.0K--
 
 
 
 
Total Other Cash Flow1.5M1.6M1.8M--
 
 
 
 
Funds From Operations-20.6M-18.2M-18.4M--
 
 
 
 
Funds From/For Other Operating Expenses270.0K333.0K798.0K--
 
 
 
 
Net Cash Flow - Operating Activities-20.9M-18.6M-19.2M--
 
 
 
 
 
InvestingIncrease In Investments-14.2M-50.8M-25.3M--
 
 
 
 
Decrease In Investments25.7M15.3M24.5M--
 
 
 
 
Capital Expenditures-25.0K-37.0K-59.0K--
 
 
 
 
Net Cash Flow Investing11.5M-35.6M-930.0K--
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction-2.4M-2.3M-2.3M--
 
 
 
 
Net Proceeds Stock Sale56.5M28.1M1.0K--
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends----------
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing54.2M25.8M-2.3M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.000.00----
 
Net Change In Cash44.8M-28.3M-22.5M0.00
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account